Delivery Order SPE2DB20D2014-SPE2DB25FC65E
- Not listed
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,221.28 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg at a ceiling value of $1,120.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and is classified as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a $5,422.99 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Losartan Potassium 100 mg tablets (1,000 count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. Valued at $1,016.18 with firm fixed pricing, this non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.94 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-competed award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is issued as a child delivery order...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) valued at $3,404.62 for 1,000 tablets of Losartan Potassium 25 mg, with a completion date of September 19, 2025. The contract was awarded on September 18, 2025, using firm fixed-price terms without set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC65EDelivery Order
The Defense Logistics Agency awarded a $4,855.20 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement, with an ultimate completion date of August 5, 2025. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency and other government healthcare system requirements. The DLA Troop Support is planning subsequent generation contracts under the Pharmaceutical Prime Vendor Global Program Generation V, with intentions to make multiple awards across separate regions, positioning AmerisourceBergen as a key participant in federal pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/4/25 |